Growing in areas that matter, cannabis medication producer Althea Group (ASX: AGH) has been increasing its global distribution offerings with the launch of its latest products; the Althea CBD25 soft gel capsules and the THC25 dried flower. Product development is the cornerstone of market share leadership in an industry still in its infancy. With the
Read More
Changes in regulation surrounding marijuana have sprouted a robust medical cannabis market showing no signs of slowing down globally. Currently, the U.S. dominates the cannabis market where the majority of States started adopting the new trend for cannabis treatment in 2012. Australia has been late to the game; we only began easing laws in early
Read More
When you think of cannabis treatment, the first compounds that come to mind are THC (tetrahydrocannabinol) and CBD (cannabidiol). With both research and development excelling for both, researchers have discovered other less-known compounds that have significant health benefits. Medicinal cannabis drug development company Bod Australia Ltd (ASX: BOD) has successfully completed a proof of concept
Read More
Food technology company Holista Colltech (ASX: HCT) has filed a patent for platform technology claiming to deliver fat-soluble medications which can be applied to the cannabidiol oil industry, making CBD oils 40 times more potent. If granted, the global patent can be applied to a whole range of molecules to create a water-soluble delivery system
Read More
Australian-based Medical Cannabis producer and supplier, Althea Group (ASX: AGH), have announced this morning that their Bristol-based medical clinic site has secured a licence from a UK independent health and social care regulator. The news suggests that medical cannabis is becoming increasingly accepted in the UK as a treatment option for chronic health conditions. Wholly
Read More